Delivery Order SPE2DB22D1017-SPE2DB25FE8CD
Award Date
10/29/24
Potential Completion Date
10/30/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML medication. The firm-fixed-price contract, valued at $1,187.60, has an ultimate completion date of July 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,992.84 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Lantus Solostar 100 unit/ml 3ml, a prescription insulin medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,926,283 units of Lantus Solostar 100 Unit/mL 3mL medical supplies. The contract has a total ceiling value of $6,618.52 and a period of performance through March 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a...
This is a $3,851.42 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lantus Solostar 100 unit/ml 3ml, a specialty medication. The order has an ultimate completion date of February 7, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded a $3,654.42 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which covers a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML at a ceiling value of $1,628.55. The contract has a performance period through May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC, designated as SPE2DX,...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,246.64 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/mL 3mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., valued at up to $999,999,999.00, which provides comprehensive pharmaceutical and medical supply support to the Department of Defense and other federal...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,278.50, is for the supply of Lantus Solostar 100 unit/mL 3mL, a diabetes medication. The contract has a period of performance through May 6, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides...
This contract award, valued at $12,007.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lantus Solostar, a 100 unit/mL, 3mL insulin product, with an ultimate completion date of April 20, 2023. This is a firm-fixed-price delivery order contract, and there is no set-aside designation, indicating open competition. In addition to this specific delivery order, AmerisourceBergen holds a larger...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of Lantus Solostar 100 unit/mL 3mL injectors. The $1,187.60 award has a performance period ending on February 5, 2024. This delivery order is part of Amerisourcebergen Drug Corp's role as the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through...